APR 10, 2019 12:26 PM PDT

Possible Non-Antibiotic Strategy for Treating Bacterial Meningitis

WRITTEN BY: Nouran Amin

Due to the increasing threat of antibiotic resistance, there is a dire need for new strategies against life threatening bacterial infections. Now, scientists at Lund University in Sweden and the University of Copenhagen have identified an alternative treatment strategy for bacterial meningitis--a serious infection that can lead to sepsis. The study was published in Nature Communications.

"The development of resistance in bacteria is accelerating and we need alternatives to antibiotics. The drug we use in the studies is a therapeutic biological product derived from humans and has already been approved for human use. They are not expensive and have also been tested against many different bacteria and infections. Bacterial meningitis is a major challenge in many parts of the world. In India, for example, it is a major cause of death among children, so there would be significant benefits there from using such a treatment strategy," says Tirthankar Mohanty, one of the researchers behind the study.

Researchers studied the cerebrospinal fluid (CSF) of patients with bacterial meningitis via advanced microscopy. They were found to be cloudy and full of lumps, which indicated neutrophil extracellular traps (NETs). Interestingly, patients with viral meningitis had CSF that was free from NETs.

"It is as though in pure frustration they turn themselves inside out in a desperate attempt to capture the bacteria they have not been able to overcome. Using this approach, they capture a number of bacteria at once in net-like structures, or neutrophil extracellular traps (NETs). This works very well in many places in the body where the NETs containing the captured bacteria can be transported in the blood and then neutralized in the liver or spleen, for example. However, in the case of bacterial meningitis these NETs get caught in the cerebrospinal space, and the cleaning station there is not very effective," explains Adam Linder, associate professor at Lund University and specialist in Infectious Diseases at Skåne University Hospital.

The researchers were aware that NETS were mostly DNA and so they wondered what would happen if you brought in drugs used for cutting up DNA, so-called DNase.

"We gave DNase to rats infected with pneumococcus bacteria, which caused bacterial meningitis, and could show that the NETs dissolved and the bacteria disappeared. It seems that when we cut up the NETs, the bacteria are exposed to the immune system, which finds it easier to combat the bacteria single-handed. We were able to facilitate a significant reduction in the number of bacteria without antibiotic intervention, says Tirthankar Mohanty.

Researchers are now looking forward to setup DNase drugs for a major international clinical study for the treatment of patients with bacterial meningitis.

Source: ScienceDaily.com

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 08, 2019
Cannabis Sciences
DEC 08, 2019
CBD Alleviates Angelman Syndrome Seizures in Mice Trial
CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurolo...
DEC 08, 2019
Genetics & Genomics
DEC 08, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
DEC 08, 2019
DEC 08, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
DEC 08, 2019
DEC 08, 2019
Does New Chinese Alzheimer's Drug Made from Seaweed Work?
It has been almost two decades since the last drug for Alzheimer’s was approved. Now, Chinese reglators have granted conditinal approval for a new dr...
DEC 08, 2019
Drug Discovery & Development
DEC 08, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
DEC 08, 2019
DEC 08, 2019
Hybrid Antibiotic Can Destroy Dangerous Staph Biofilms
When staph begins to grow on medical devices like implants used on wounds, artificial joints, or catheters, they can cause chronic, serious infections....
Loading Comments...